Marleen van de Sande

1.4k total citations
16 papers, 708 citations indexed

About

Marleen van de Sande is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Marleen van de Sande has authored 16 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 8 papers in Immunology and 2 papers in Hematology. Recurrent topics in Marleen van de Sande's work include Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Marleen van de Sande is often cited by papers focused on Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Marleen van de Sande collaborates with scholars based in Netherlands, United States and United Kingdom. Marleen van de Sande's co-authors include Dominique Baeten, Paul P. Tak, Troy Noordenbos, Juan D. Cañete, Nataliya Yeremenko, Robert Landewé, Désirée van der Heijde, Roberta Ramonda, Inger Jorid Berg and Anoek de Koning and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Marleen van de Sande

14 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marleen van de Sande Netherlands 10 593 427 218 88 51 16 708
Emanuele Cassarà Italy 14 494 0.8× 221 0.5× 191 0.9× 23 0.3× 40 0.8× 21 661
Christiane Reindl Germany 6 288 0.5× 341 0.8× 149 0.7× 20 0.2× 67 1.3× 7 581
Rasho Rashkov Bulgaria 12 250 0.4× 173 0.4× 47 0.2× 96 1.1× 74 1.5× 47 475
Kirsten Mackay United Kingdom 9 704 1.2× 334 0.8× 162 0.7× 156 1.8× 78 1.5× 13 821
Jinxian Huang China 12 226 0.4× 142 0.3× 78 0.4× 33 0.4× 118 2.3× 41 380
Eva Tomero Spain 12 304 0.5× 153 0.4× 78 0.4× 12 0.1× 112 2.2× 31 470
Tobias Russell United Kingdom 9 212 0.4× 192 0.4× 104 0.5× 26 0.3× 72 1.4× 15 370
G. Ibrahim United Kingdom 7 679 1.1× 490 1.1× 311 1.4× 7 0.1× 30 0.6× 7 803
L Bradbury United Kingdom 9 432 0.7× 209 0.5× 113 0.5× 27 0.3× 99 1.9× 28 542
Concepción Moll Spain 7 195 0.3× 105 0.2× 41 0.2× 38 0.4× 44 0.9× 12 342

Countries citing papers authored by Marleen van de Sande

Since Specialization
Citations

This map shows the geographic impact of Marleen van de Sande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen van de Sande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen van de Sande more than expected).

Fields of papers citing papers by Marleen van de Sande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen van de Sande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen van de Sande. The network helps show where Marleen van de Sande may publish in the future.

Co-authorship network of co-authors of Marleen van de Sande

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen van de Sande. A scholar is included among the top collaborators of Marleen van de Sande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen van de Sande. Marleen van de Sande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ramiro, Sofía, M. van Lunteren, Robert Landewé, et al.. (2024). Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the Rheumatic Diseases. 83(5). 589–598. 15 indexed citations
2.
Ramiro, Sofía, Anne Boel, M. van Lunteren, et al.. (2024). Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?. Lara D. Veeken. 64(4). 1826–1834. 1 indexed citations
3.
Navarro‐Compán, Victoria, Diego Benavent, Désirée van der Heijde, et al.. (2023). ASAS consensus definition of early axial spondyloarthritis. Annals of the Rheumatic Diseases. 83(9). 1093–1099. 36 indexed citations
4.
Braun, Jürgen, Ricardo Blanco, Helena Marzo‐Ortega, et al.. (2023). Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis. Arthritis Research & Therapy. 25(1). 80–80. 9 indexed citations
5.
Alava, Mónica Hernández, Allan Wailoo, F. van Gaalen, et al.. (2022). Measuring quality of life of patients with axial spondyloarthritis for economic evaluation. RMD Open. 8(1). e001955–e001955. 3 indexed citations
6.
Braun, Jürgen, Ricardo Blanco, Helena Marzo‐Ortega, et al.. (2021). Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis Research & Therapy. 23(1). 231–231. 21 indexed citations
7.
Chen, Sijia, Melissa N. van Tok, Désiree Pots, et al.. (2020). mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo. Frontiers in Immunology. 10. 2344–2344. 30 indexed citations
8.
Deodhar, Atul, Ricardo Blanco, Eva Dokoupilová, et al.. (2020). Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study. Arthritis & Rheumatology. 73(1). 110–120. 113 indexed citations
9.
Sande, Marleen van de, Leonieke van Mens, Silvia Menegatti, et al.. (2018). O015 Il-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses. Annals of the Rheumatic Diseases. 77. A8–A8. 2 indexed citations
10.
11.
Yeremenko, Nataliya, Troy Noordenbos, Tineke Cantaert, et al.. (2012). Disease‐specific and inflammation‐independent stromal alterations in spondylarthritis synovitis. Arthritis & Rheumatism. 65(1). 174–185. 52 indexed citations
12.
Baarsen, Lisa G. M. van, Maria J. H. de Hair, Tamara H. Ramwadhdoebé, et al.. (2012). Investigating the cellular composition of lymph nodes in preclinical and early inflammatory arthritis: a feasibility study. Annals of the Rheumatic Diseases. 71. A20–A20. 4 indexed citations
13.
Noordenbos, Troy, Nataliya Yeremenko, Marleen van de Sande, et al.. (2011). Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis & Rheumatism. 64(1). 99–109. 226 indexed citations
14.
Abreu, Joana R. F., M. Sanders, Aleksander M. Grabiec, et al.. (2009). The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue. Arthritis Research & Therapy. 11(4). R121–R121. 20 indexed citations
15.
Löwenthal, A., et al.. (1957). Variations dans l'excrétion urinaire des ions K et Na dans les suites des interventions neurochirurgicales. 26(2). 112–122.
16.
Löwenthal, A., et al.. (1957). [Variations in the urinary excretion of potassium & sodium ions in the sequels of neurosurgical interventions].. PubMed. 26(2). 112–22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuele Cassarà Breakdown of academic impact, for papers by Christiane Reindl Breakdown of academic impact, for papers by Rasho Rashkov Breakdown of academic impact, for papers by Kirsten Mackay Breakdown of academic impact, for papers by Jinxian Huang Breakdown of academic impact, for papers by Eva Tomero Breakdown of academic impact, for papers by Tobias Russell Breakdown of academic impact, for papers by G. Ibrahim Breakdown of academic impact, for papers by L Bradbury Breakdown of academic impact, for papers by Concepción Moll
Rankless by CCL
2026